California Technology Ventures
VC Fund
Pasadena, United States
California Technology Ventures is a VC fund in Pasadena focused on Health Care and Medical Device. California Technology Ventures, LLC (CTV) is a venture capital fund that makes direct investments in technology and life science companies. CTV has built a strong reputation for its entrepreneurial approach to investing and working with companies. Unlike many investment funds, CTV can invest the smaller amounts required by early-stagecompanies, as well as larger investments for later-stage expansion. Initial investments typically range from $250,000 to $2 million, with up to $5 million over the life of the investment. CTV participates in seed/start-up companies, first and second round investments, and later stage investments.CTV invests primarily in companies engaged in the following industries:Information & Communications Technology, such as computer hardware, telecommunications, electronics, semiconductors, software and systems, multi-media, and Internet;Life Sciences, such as bio-pharmaceuticals and medical devices;When considering funding a company, CTV looks for:Experienced and capable management;Unique, "must-have" or proprietary products or services that meet a pressing need;The opportunity to create a leadership position in a large and growing industry;A compelling business model with clearly-defined milestones to reach profitability;A defensible and sustainable competitive position.
- Total investments:
- 41
- Last investment:
- Lead investor:
- 27%
- Fund size:
- $100M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries California Technology Ventures invests in
Stages California Technology Ventures invests in
Countries California Technology Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $600k–$13M
- Series B
- $2.3M–$32M
- Series C
- $4.4M–$50M
Investment Focus
Industry
- Health Care 8 (20%)
- Medical Device 8 (20%)
- Biotechnology 7 (17%)
- Medical 5 (12%)
- Software 4 (10%)
Stage
- Series A 8 (20%)
- Series B 8 (20%)
- Series C 7 (17%)
- Series D 5 (12%)
- Series F 3 (7%)
Country
- United States 21 (51%)
- China 1 (2%)
- Finland 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Alexander Suh
Founding Managing Director
|
Founding Managing Director | Total investments: 1 | Find email | |
Andrea DeVita
Director of Finance
|
Director of Finance | Total investments: 0 | Find email | |
Jane Cassidy
Administration
|
Administration | Total investments: 0 | Find email | |
William A. Hanna
Managing Director
|
Managing Director | Total investments: 3 | Find email | |
|
Jo Bowen
Co-Founder
|
Co-Founder | Total investments: 0 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Motive
|
Motive develops technology that connects and automates physical operations for businesses across various industries. The company provides a platform that combines telematics, fleet management, compliance tools, equipment monitoring, and AI-powered safety solutions. Its products help companies track vehicles, monitor driver behavior, automateworkflows, and ensure regulatory compliance through real-time data and analytics. Motive also offers integrated solutions for spend management and maintenance, enabling businesses to control costs and improve operational efficiency. The platform supports diverse sectors including trucking, construction, oil and gas, and agriculture by centralizing data and enabling actionable insights. Through automation and visibility, Motive helps organizations optimize asset utilization and enhance decision-making in day-to-day operations. | $150M / Series F / May 25, 2022 | |
Rally
|
Rally provides a blockchain platform for the development of video streaming and gaming apps and is an open network that uses the Ethereum blockchain to enable creators to build vibrant and self-sustaining economies with their communities. Rally allows anyone with an online community to create their own coin without having to learn how to code onthe Ethereum blockchain. Rally is a decentralized platform that is entirely controlled by its users. This means that creators and their communities can use their social tokens on any social platform | Venture - Series Unknown / Jan 19, 2021 | |
AIVITA Biomedical
|
AiVita Biomedical is is a medicine company, develops commercial and clinical stage programs utilizing curative and regenerative medicines. AIVITA Biomedical is a privately held company engaged in the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. AIVITA Biomedical utilizes its expertise in stemcell growth and directed, high-purity differentiation to enable safe, efficient and economical manufacturing systems which support its products and therapeutic pipeline. | $25M / Series B / Dec 29, 2020 | |
Sky
|
Maker is a decentralized autonomous organization on the Ethereum blockchain. | $25M / Secondary Market / Apr 26, 2019 | |
MariaDB
|
MariaDB is a new generation database company whose products reach more than a billion users through Linux distributions and have been downloaded over one billion times. | $27M / Series C / Sep 29, 2017 | |
OrthAlign
|
OrthAlign is a privately-held medical device company providing healthier and more pain-free lifestyles to joint replacement patients. The company is developing a line of computer-assisted surgical devices that distill the critical features and benefits of large surgical navigation systems. Its goal is to create a new standard of care in total jointreplacement, making consistent, and measurable results accessible to surgeons and patients.The company was founded in 2009 and based in Aliso Viejo, California. | $10M / Series D / Sep 27, 2017 | |
Gamevice
|
Gamevice is a US based award winning design and engineering business creating touch screen tablets and game controllers. Gamevice has offices in Hong Kong, London, and new offices opening in Shenzhen China. Its corporate head office is based in Los Angeles as is the R&D and support center. | $12.5M / Series A / May 31, 2017 | |
|
AIVITA Biomedical
|
AiVita Biomedical is is a medicine company, develops commercial and clinical stage programs utilizing curative and regenerative medicines. AIVITA Biomedical is a privately held company engaged in the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. AIVITA Biomedical utilizes its expertise in stemcell growth and directed, high-purity differentiation to enable safe, efficient and economical manufacturing systems which support its products and therapeutic pipeline. | $2M / Series A / Jun 06, 2016 | |
Spine Wave
|
Spine Wave engages in developing and marketing medical devices for the treatment of spinal disorders. It focuses on commercializing technology platforms that offer surgical solutions for spine surgeons and their patients. Spine Wave offers expandable PEEK spacers and expandable interbody devices for posterior surgery; pivoting spacer systems;lateral spacer systems, XDL expandable devices, and lateral access systems for lateral stabilization; Leva PX, an expandable interbody device for the treatment of spinal disorders; GraftMag Graft Delivery System to deliver large amounts of bone graft; and fixation products such as spine systems for treating degeneration, deformity, tumor, and trauma of the thoracolumbar spine as well as adjacent level systems. Spine Wave also offers anterior cervical plate systems that provide stabilization as an adjunct to spinal fusion from C2-C7 through anterior screw fixation; and cervical spacer systems to treat degenerative disc disease from C2-T1. It offers its products through distributors. John Pafford and Mark LoGuidice founded Spine Wave on February 1, 2001. It has its headquarters in Shelton in Connecticut. | $11M / Series F / May 31, 2016 | |
|
MariaDB
|
MariaDB is a new generation database company whose products reach more than a billion users through Linux distributions and have been downloaded over one billion times. | $9M / Series B / Jan 21, 2016 | |
| See all 41 investments → | |||
Co-Investors
Aphelion Capital
6 deals together
Azure Capital Partners
5 deals together
New Enterprise Associates
4 deals together
Psilos Group
4 deals together
Research Corporation Technologies
4 deals together
RC Capital
4 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does California Technology Ventures invest in?
California Technology Ventures invests primarily in Health Care, Medical Device and Biotechnology startups, most often at Series A and Series B stage. Most of the 41 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is California Technology Ventures's check size?
California Technology Ventures typically joins rounds of $600k–$13M at Series A, $2.3M–$32M at Series B and $4.4M–$50M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds California Technology Ventures participates in.
How do I contact California Technology Ventures?
Public channels for California Technology Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at California Technology Ventures?
The team at California Technology Ventures includes Alexander Suh (Founding Managing Director), Andrea DeVita (Director of Finance) and Jane Cassidy (Administration), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
